Considerations on Multimorbidity and Frailty in Inflammatory Bowel Diseases

Overview

Journal J Crohns Colitis

Publisher Oxford University Press

Date 2024 Oct 30

PMID 39475079

Authors

Isabel Carbery

Christian P Selinger

Oliver Todd

Shaji Sebastian

Affiliations

Soon will be listed here.

Abstract

There are growing numbers of older people with inflammatory bowel diseases [IBD]. These older patients are more likely to have other comorbidities and polypharmacy, which can make recognizing and treating IBD complex. Frailty is a newer concept in the IBD field, and we are beginning to recognize the importance of this as a marker of biological age and its association with risk of adverse IBD-related outcomes. In this review article we aim to provide practical insight into the specific challenges facing older patients and their clinicians at each stage of the patient journey. We also discuss the latest understanding of the impact of frailty for these patients with IBD and highlight areas for future research.

References

Zammarchi I, Lanzarotto F, Cannatelli R, Munari F, Benini F, Pozzi A . Elderly-onset vs adult-onset ulcerative colitis: a different natural history?. BMC Gastroenterol. 2020; 20(1):147. PMC: 7216336. DOI: 10.1186/s12876-020-01296-x. View

Huang X, Xiao M, Jiang B, Wang X, Tang X, Xu X . Prevalence of frailty among patients with inflammatory bowel disease and its association with clinical outcomes: a systematic review and meta-analysis. BMC Gastroenterol. 2022; 22(1):534. PMC: 9773593. DOI: 10.1186/s12876-022-02620-3. View

Cristina M, Spagnolo A, Giribone L, Demartini A, Sartini M . Epidemiology and Prevention of Healthcare-Associated Infections in Geriatric Patients: A Narrative Review. Int J Environ Res Public Health. 2021; 18(10). PMC: 8156303. DOI: 10.3390/ijerph18105333. View

Desai A, Zator Z, de Silva P, Nguyen D, Korzenik J, Yajnik V . Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2012; 19(2):309-15. PMC: 4345352. DOI: 10.1002/ibd.23026. View

Saad Alshahrani A, Mohammad D, Attieh Alzahrani M, Narula N . Vedolizumab does not increase risk of clostridium difficile infection in patients with inflammatory bowel disease using vedolizumab: A retrospective cohort study. Saudi Pharm J. 2023; 31(9):101736. PMC: 10448164. DOI: 10.1016/j.jsps.2023.101736. View

Qian A, Nguyen N, Elia J, Ohno-Machado L, Sandborn W, Singh S . Frailty Is Independently Associated with Mortality and Readmission in Hospitalized Patients with Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2020; 19(10):2054-2063.e14. PMC: 7930013. DOI: 10.1016/j.cgh.2020.08.010. View

Collard R, Boter H, Schoevers R, Oude Voshaar R . Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc. 2012; 60(8):1487-92. DOI: 10.1111/j.1532-5415.2012.04054.x. View

Velissaris D, Pantzaris N, Koniari I, Koutsogiannis N, Karamouzos V, Kotroni I . C-Reactive Protein and Frailty in the Elderly: A Literature Review. J Clin Med Res. 2017; 9(6):461-465. PMC: 5412518. DOI: 10.14740/jocmr2959w. View

Tadin Hadjina I, Zivkovic P, Matetic A, Rusic D, Vilovic M, Bajo D . Impaired neurocognitive and psychomotor performance in patients with inflammatory bowel disease. Sci Rep. 2019; 9(1):13740. PMC: 6760518. DOI: 10.1038/s41598-019-50192-2. View

10.

G Williams J, Cheung W, Russell I, Cohen D, Longo M, Lervy B . Open access follow up for inflammatory bowel disease: pragmatic randomised trial and cost effectiveness study. BMJ. 2000; 320(7234):544-8. PMC: 27297. DOI: 10.1136/bmj.320.7234.544. View

11.

Bagdasarian N, Rao K, Malani P . Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015; 313(4):398-408. PMC: 6561347. DOI: 10.1001/jama.2014.17103. View

12.

Sacleux S, Sarter H, Fumery M, Charpentier C, Guillon-Dellac N, Coevoet H . Post-operative complications in elderly onset inflammatory bowel disease: a population-based study. Aliment Pharmacol Ther. 2018; 47(12):1652-1660. DOI: 10.1111/apt.14790. View

13.

Salvatori S, Marafini I, Franchin M, Lavigna D, Brigida M, Venuto C . Reversibility of Frail Phenotype in Patients with Inflammatory Bowel Diseases. J Clin Med. 2023; 12(7). PMC: 10095533. DOI: 10.3390/jcm12072658. View

14.

Everhov A, Halfvarson J, Myrelid P, Sachs M, Nordenvall C, Soderling J . Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden. Gastroenterology. 2017; 154(3):518-528.e15. DOI: 10.1053/j.gastro.2017.10.034. View

15.

Clegg A, Young J, Iliffe S, Rikkert M, Rockwood K . Frailty in elderly people. Lancet. 2013; 381(9868):752-62. PMC: 4098658. DOI: 10.1016/S0140-6736(12)62167-9. View

16.

Sasson A, Sheehan G, Yu A, Gupta A, Ling K, Kochar B . Yield and Predictors of Surveillance Colonoscopies in Older Adults With Long-standing Ulcerative Colitis. Clin Gastroenterol Hepatol. 2021; 20(6):e1353-e1364. DOI: 10.1016/j.cgh.2021.08.019. View

17.

Borren N, Ananthakrishnan A . Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2019; 17(9):1736-1743.e4. PMC: 6609492. DOI: 10.1016/j.cgh.2018.12.032. View

18.

Bellera C, Rainfray M, Mathoulin-Pelissier S, Mertens C, Delva F, Fonck M . Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol. 2012; 23(8):2166-2172. DOI: 10.1093/annonc/mdr587. View

19.

Khan N, Vallarino C, Lissoos T, Darr U, Luo M . Risk of Malignancy in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients. Drugs Aging. 2017; 34(11):859-868. PMC: 5705754. DOI: 10.1007/s40266-017-0498-y. View

20.

Frey N, Venturelli S, Zender L, Bitzer M . Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics. Nat Rev Gastroenterol Hepatol. 2017; 15(2):81-95. DOI: 10.1038/nrgastro.2017.146. View